EIDOS THERAPEUTICS INC's ticker is EIDX and the CUSIP is 28249H104. A total of 123 filers reported holding EIDOS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.50 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $147,847,000 | +160.4% | 1,123,630 | 0.0% | 25.39% | +40.0% |
Q3 2020 | $56,777,000 | +6.0% | 1,123,630 | 0.0% | 18.14% | -11.3% |
Q2 2020 | $53,563,000 | -2.7% | 1,123,630 | 0.0% | 20.44% | -14.8% |
Q1 2020 | $55,047,000 | -14.6% | 1,123,630 | 0.0% | 23.98% | -2.9% |
Q4 2019 | $64,485,000 | +59.5% | 1,123,630 | 0.0% | 24.71% | +17.3% |
Q3 2019 | $40,417,000 | +15.7% | 1,123,630 | 0.0% | 21.07% | +41.3% |
Q2 2019 | $34,922,000 | +32.5% | 1,123,630 | 0.0% | 14.92% | -25.7% |
Q1 2019 | $26,349,000 | +70.4% | 1,123,630 | 0.0% | 20.07% | +23.2% |
Q4 2018 | $15,461,000 | – | 1,123,630 | – | 16.29% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
IFP Advisors, Inc | 0 | $0 | 0.00% |